Evidence map›Paper›PMID 24170800›Full record

ArticleDento maxillo facial radiology2014

Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model.

N Ersan, L J van Ruijven, A L J J Bronckers, V Olgaç, D Ilgüy, V Everts

Registry-linked trialAbstract readComparative Study
In one paragraph

Article in Dento maxillo facial radiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06061354 (Bone Microarchitecture and Implant Stabilization in Atrophic Jaws Reconstructed With Bone Grafts Treated With Teriparatide), which is not on this map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06061354 phase4unknown statusnot on this mapstarted 2023, after this paper: background citation

Bone Microarchitecture and Implant Stabilization in Atrophic Jaws Reconstructed With Bone Grafts Treated With Teriparatide

TypeinterventionalSponsorUniversidad de ValparaisoRan2023 to 2024Enrolled42ConditionsBone RegenerationArmsTeriparatide, Maxillary Sinus Augmentation, Dental Implant Installation, Bone graft
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. A comparative effectiveness pilot study of teriparatide for medication-related osteonecrosis of the jaw: daily versus weekly administration.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2020
    Article
  10. Article
  11. StandardizedClinical, cosmetic and investigational dentistry · 2020
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. The effect of laser therapy on the expression of osteocalcin and osteopontin after tooth extraction in rats treated with zoledronate and dexamethasone.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2016
    Article
  17. Article
  18. Applications of Teriparatide for Alveolar Bone Regeneration: A Systematic Review.Journal of International Society of Preventive & Community Dentistry
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

N ErsanDepartment of Dentomaxillofacial Radiology, Faculty of Dentistry, Yeditepe University, Istanbul, Turkey.
L J van Ruijven
A L J J Bronckers
V Olgaç
D Ilgüy
V Everts
University of Amsterdam · NLYeditepe University · TRIstanbul University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe objectives of this study were to establish a bisphosphonate-related osteonecrosis of the jaw (BRONJ) rat model and to analyse the effects of teriparatide (TP) on this model.

methodsSprague-Dawley rats were divided into three groups: I-zoledronic acid (ZA, n = 10); II-ZA and teriparatide (ZA + TP, n = 10); III-control (n = 10). Osteonecrosis was induced by administering zoledronic acid to groups ZA and ZA + TP. A week after the injections, rats underwent extraction of the first left mandibular molar. Following a four week period, TP was administered to the ZA + TP group for 28 days. Upon killing, extraction sockets were examined clinically, radiologically and histopathologically.

resultsClinical examination revealed necrotic bone exposure in none of the animals. MicroCT (µCT) examination showed that bone mineral density of the newly formed bone in the extraction socket was lower in the ZA group than in the ZA + TP group (p < 0.05). Histopathological examination revealed that only the ZA and ZA + TP groups developed osteonecrosis, and the osteonecrotic bone area in the ZA group was larger than that in the ZA + TP group (p < 0.05). Tartrate-resistant acid phosphatase (TRAcP) enzyme histochemistry revealed that the number of detached and large osteoclasts were higher in the ZA group than in other groups, whereas the number of apoptotic osteoclasts in both ZA and ZA + TP groups were higher than in the control group (p < 0.05).

conclusionsOur data indicate that bisphosphonate-related osteonecrosis of the jaw model used in the present study is an attractive model to investigate treatment modalities and that TP might be an effective treatment in BRONJ.

Indexed as

Acid PhosphataseAlveolar ProcessAnimalsApoptosisBiomarkersBisphosphonate-Associated Osteonecrosis of the JawBone DensityBone Density Conservation AgentsBone MarrowCell AdhesionCell CountDiphosphonatesDisease Models, AnimalFemaleImidazolesInjections, IntraperitonealAcid PhosphataseBiomarkersBone Density Conservation AgentsDiphosphonatesImidazolesIsoenzymesTartrate-Resistant Acid PhosphataseTeriparatideZoledronic Acidbisphosphonate-associated osteonecrosis of the jawMicrocomputed tomographytartrate-resistant acid phosphataseteriparatidezoledronic acid

Identifiers

PMID24170800
PMCPMC3887480
OpenAlexW2164250472

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.